Sachs Associates
Sachs Associates is a privately held international conference company (founded 1999, dual HQ in London and Basel) that organizes more than 13 annual life-sciences investor and partnering forums across Bio-Pharma, Medtech, and Digital Health, serving pharma business-development teams, institutional healthcare investors, biotechs, and service providers.
- Company typePrivate
- Founded1999
- HeadquartersLondon, United Kingdom
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Sachs Associates does
Sachs Associates is a privately held international conference company that has organized life-sciences and health-tech investor and partnering forums since 1999. The company operates a portfolio of more than 13 annual and periodic events spanning Bio-Pharma, Medtech, and Digital Health, including the 26th Annual Biotech in Europe Forum, the 19th European Life Sciences CEO Forum, the 10th Neuroscience Innovation Forum, the 6th Digital Immuno-Oncology Innovation Forum, and newer forums in obesity/cardiometabolic and European healthcare impact. Events are held in key life-sciences hubs including Basel, Zurich, London, San Francisco, New Orleans, and Chicago, with both in-person and virtual participation formats.
The core technology consists of SachsForum.com, a web platform for event information, registration, and post-event content access, and a third-party online One-2-One Meeting System (Meeting Mojo) that enables delegates to schedule private 20-minute meetings in secured rooms. The company does not operate any proprietary AI/ML systems; its technology layer is a thin SaaS integration supporting a primarily live, people-driven business.
Sachs Associates generates revenue from four streams: (i) registration fees from corporate/biotech/medtech delegates and service providers, with complimentary passes for qualified institutional, private equity, and venture investors; (ii) tailored sponsorship packages for pharma, biotech, investment funds, and service providers; (iii) limited table-top exhibitions at physical venues and virtual exhibition packages; and (iv) corporate presenting opportunities, including 20-minute and 10-minute in-person slots and pre-recorded virtual presentations. Customer segments are predominantly pharma and biotech business-development teams, institutional and specialist healthcare investors, sell-side analysts, and consultants/CROs. Distribution is primarily direct via the SachsForum.com site, supplemented by partnerships with industry associations (BioIndustry Association, BioPartner, Swiss Biotech Association) and service partners (Edison Group, FreeMind, MEDiSTRAVA, Tiberend, Biotechgate).
Sachs Associates firmographics
Firmographics- Name
- Sachs Associates
- Legal name
- Sachs Associates Switzerland AG
- Website
- https://sachsforum.com
- Company type
- Private
- Founded year
- 1999
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Sachs Associates is a privately held international conference company (founded 1999, dual HQ in London and Basel) that organizes more than 13 annual life-sciences investor and partnering forums across Bio-Pharma, Medtech, and Digital Health, serving pharma business-development teams, institutional healthcare investors, biotechs, and service providers.
- Ownership category
- akta.pro rank
Sachs Associates industry classification
Industry- Product category
- Life Sciences Conferences and Investor Forums
- NAICS
- Convention and Trade Show Organizers (56192)
- akta.pro primary industry
- Corporate Conferences & Sales Kickoffs (MPAGAGAC)
- akta.pro secondary industries
- Executive Summits & Invitation-Only Forums (MPAGAGAK), Finance & Investment Conferences (MPAGAGAG), Exhibitor/Sponsor Management (Corporate Conferences) (THACAFAN)
Keywords
Where Sachs Associates is headquartered
LocationHeadquarters
- HQ city
- London
- HQ country
- United Kingdom
- HQ region
- Europe
Offices2 records
Markets served
Sachs Associates business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Others
Revenue model
- Conference Registration Fees: Revenue generated from registration fees for conference attendance. The company offers complimentary passes for qualified institutional (buy/sell-side), private equity, and venture investors, while other participants may purchase access for in-person or virtual participation.
- Sponsorship Packages: Tailored sponsorship packages for events including conference sponsorship, workshops, and social events. Sponsors gain profile elevation directly with potential clients attending industry-driven events.
- Exhibition Stands: Revenue from table-top exhibitions at physical venues and virtual exhibition packages for remote participants. Exhibitors gain leads, introduce products and services, and build relationships with key decision-makers.
- Corporate Presentations: Companies can purchase presenting opportunities including 20-minute or 10-minute in-person presentations at dedicated tracks, or pre-recorded presentations available to registered attendees on the event portal.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Freemium | Annual | Complimentary Investor Pass |
| Subscription | Per event | Corporate Presenting Package |
| Subscription | Per event | Exhibition Package |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels4 records
Sachs Associates product offering
Product offeringCore offering
Sachs Associates organizes and runs international conferences and forums for the life sciences industry, focused on biotech, medtech, and digital health sectors. Its core deliverable is the SachsForum event platform and the annual forum portfolio (BEF, ELSF, NIF, OCIF, BOIF, IOIF, EHIS, among others), which provide licensing, investment, and partnering opportunities through panel discussions, company presentations, exhibitions, and a One-2-One meeting system for delegates. Revenue is generated from paid corporate registrations, sponsorship packages, exhibition stands, and corporate presentation slots, while qualified institutional investors receive complimentary passes.
Product overview
Sachs Associates operates SachsForum, a conference platform hosting multiple specialized life sciences forums across Europe and the USA. The portfolio includes annual events focused on Bio-Pharma, Medtech and Digital Health sectors, including the Biotech in Europe Forum (BEF), European Life Sciences CEO Forum (ELSF), Neuroscience Innovation Forum (NIF), Obesity & Cardiometabolic Innovation Forum (OCIF), BioPharma Obesity Innovation Forum (BOIF), and Immuno-Oncology Innovation Forum (IOIF). The core platform provides Online One-2-One Meeting System for networking and deal-making, with supplementary services including corporate presentation opportunities, exhibition stands, and sponsorship packages. Events offer both in-person and virtual participation options with dedicated presenting tracks and networking facilities.
Differentiator
Problem solved
Functional benefit
Products and services
- SachsForum Platform Digital platform hosting Sachs Associates' life sciences conference portfolio, providing event information, registration, networking, and access to forums across Bio-Pharma, Medtech and Digital Health sectors.
- 26th Annual Biotech in Europe Forum (BEF) Annual European forum for biotech companies focused on licensing and investment opportunities; one of the longest-running biotech investor forums in Europe.
- 19th Annual European Life Sciences CEO Forum (ELSF) Annual European forum bringing together life sciences CEOs, investors and industry leaders for business development and investment discussions.
- 10th Annual Neuroscience Innovation Forum (NIF) Annual forum focused on neuroscience innovation, bringing together neuroscience research leaders, patient advocacy groups, investors, pharmas and biotechs for licensing and investment opportunities.
- 2nd Annual Obesity & Cardiometabolic Innovation Forum (OCIF) Annual forum connecting obesity, diabetes and cardiometabolic breakthroughs, focused on next-generation cardiometabolic science and market transformation, with 200+ in-person delegates and 15+ company presentations.
- 1st Annual BioPharma Obesity Innovation Forum (BOIF) Annual forum focused on obesity science, drug development, technology and investment, bringing together pharma companies, biotechs and investors.
- 6th Annual Digital Immuno-Oncology Innovation Forum (IOIF) Annual digital forum focused on immuno-oncology innovation, bringing together cancer research institutes, patient advocacy groups, investors, pharmas and biotechs, with 400+ attendees from 27 countries.
- 1st Annual European Healthcare Impact Summit (EHIS) Annual forum focused on European healthcare impact, bringing together healthcare stakeholders for business development, licensing and investment opportunities.
- 1st Annual European Neuroscience Innovation Forum (ENIF) Forum focused on European neuroscience innovation, providing networking and partnering opportunities for the neuroscience community.
- 1st Annual European Biotech Obesity Innovation Forum (EBOIF) Forum focused on European biotech obesity innovation, connecting science, drug development and investment opportunities.
- Exhibition and Sponsorship Packages Tailored sponsorship and marketing packages including conference sponsorship, table-top exhibition stands (limited to 2-3 companies at physical venues), and promotional material distribution to raise company profile with potential clients.
- Corporate Presentation Opportunities Presenting slots allowing companies to deliver 20-minute or 10-minute in-person presentations at dedicated tracks, or pre-recorded presentations accessible to registered attendees on the event portal, to showcase investment and partnering opportunities.
Quantifiable outcome
- 400+ people from 27 countries attended the virtual 6th Annual Digital Immuno-Oncology Innovation Forum
- +1 more outcomes
Companies that use Sachs Associates
Customer profileNamed customers6 records
Segments4 records
Ideal customer profiles3 records
Sachs Associates technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
Sachs Associates partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered minor and core.
- BioIndustry Association (BIA)minorThe BioIndustry Association (BIA) is the trade association for innovative life sciences and biotech industry in the UK, counting over 460 companies including start-ups, biotechnology, universities, research centres, investors, and lawyers among its members. They serve as a supporter for the Neuroscience Innovation Forum.
- BioPartnerminorBioPartner is an independent, government-accredited trade organisation, promoting international partnering for trade, investment and collaborations with UK Life Science companies. They assist companies with access to government grants and heavily discounted entry fees.
- Swiss Biotech AssociationcoreSwiss Biotech unites the four leading biotech regions of Switzerland (BioAlps, BaselArea, Biopolo Ticino and Greater Zurich Area). The association represents more than 150 companies and profiles Switzerland as a top biotech location, raising the country's economic profile in Europe.
- Edison GroupminorEdison is a content-led IR business that helps companies stand out and meet the right shareholders through expert analyst content, digital targeting, and active investor engagement. They drive liquidity and valuations for their clients.
- FreeMind GroupminorFreeMind is a consulting group established in 1999 that assists in maximizing potential to receive funding from non-dilutive sources. They have garnered their clients over 1.5 billion dollars to date.
- MEDiSTRAVA ConsultingminorMEDiSTRAVA Consulting is a strategic communications and healthcare advisory group that channels global expertise across corporate communications, investor relations, medical and regulatory affairs, HEOR and market access to enable biotech and pharma clients to achieve their full potential.
- Tiberend Strategic Advisors, Inc.minorTiberend Strategic Advisors is a corporate communications firm providing media strategy and execution for life science companies including biotech, medical devices, and diagnostics. They work with emerging growth companies to enhance valuation.
Scale indicators5 records
Recent moves6 records
Expansion highlights5 records
Sachs Associates competitors and assessment
Company assessmentDirect peers
- EBD Group (BIO Partnering): EBD Group operates the BIO One-on-One Partnering events, the largest biotech-pharma licensing and investor partnering conferences globally. Directly comparable to Sachs Associates' SachsForum biotech partnering forums in audience (pharma BD, biotech executives, investors), business model (registration + partnering platform + sponsorships), and core offering (One-2-One meetings to drive licensing and investment deals).
- Cambridge Healthtech Institute (CHI): Cambridge Healthtech Institute runs a portfolio of biotech and pharmaceutical conferences including the PepTalk, Molecular Medicine Tri-Conference, and Immuno-Oncology Summit series. Directly comparable to Sachs Associates in audience (biotech execs, investors, pharma BD), conference-led business model, and therapeutic-area focused content streams such as immuno-oncology.
- Hanson Wade: Hanson Wade is a specialist B2B conference organizer running hundreds of biotech, medtech, and digital health forums across therapeutic areas. Closely comparable to Sachs Associates in niche therapeutic-area strategy, pharma/biotech investor audience, and conference-with-partnering-meetings format; positioned as a pure-play emerging competitor in Sachs Associates' core verticals.
- Terrapinn (now Agenda): Terrapinn's Life Sciences division (now Agenda) runs pharma and biotech conferences (e.g., Total Biopharma, Antibodies Network). Comparable to Sachs Associates in event-led life sciences business model and pharma/biotech audience, with a similar mix of investor and corporate attendees and emerging therapeutic-area specializations.
- BioFIT (Event): BioFIT is a European life sciences partnering event focused on early-stage innovation, licensing deals, and investor-academic collaboration. Directly comparable to Sachs Associates' European biotech partnering forums (BEF, ELSF) in audience (biotech startups, pharma BD, investors) and partnering-meeting driven event format, with similar European geographic focus.
Broad incumbents
- Informa (Life Sciences / Pharma Intelligence): Informa is a global B2B events and information services group running a large portfolio of life sciences conferences, summits, and digital communities (e.g., CPHI, BIO-Europe partners, FT Live life sciences). Overlaps with Sachs Associates across pharma/biotech event formats and investor-attended forums, but operates at vastly greater scale and offers year-round data, media, and event products as a wider portfolio.
- Drug Information Association (DIA): DIA is a global life sciences membership organization running large regulatory, clinical, and pharma conferences and training programs. Adjacent to Sachs Associates' pharma/biotech event focus, but DIA's scale (thousands of attendees), diversified training/certification revenue, and non-profit orientation differentiate it from Sachs Associates' investor-partnering specialty.
- BIO (Biotechnology Innovation Organization): BIO is the largest US trade association for the biotech industry and runs BIO Convention, BIO Europe, and BIO Investor Forum events. Partially overlaps Sachs Associates' investor/partnering conference focus through BIO Europe and BIO Investor Forum, but operates as a trade association with broader advocacy, policy, and member-service mandates beyond pure events.
Emerging players
- Fierce Biotech / Fierce Pharma Events: Fierce Biotech operates media and events serving pharma and biotech executives including investor conferences and partnering forums. Comparable to Sachs Associates in audience overlap (biotech executives, pharma BD, investors), but with a stronger media-led model and only a partial event portfolio rather than Sachs Associates' event-pure focus.
- BioCentury Inc. BioCentury is a long-running biotech media and events business (including the BioCentury Grand Rounds Conference and Investor conferences). Comparable to Sachs Associates in biotech investor/partnering event focus and established industry relationships, though heavier on media/data products and lighter on therapeutic-area niche forums than Sachs Associates.
Market position
Strengths5 records
Weaknesses4 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Sachs Associates social profiles
Digital presenceSachs Associates financial estimates
Financial estimateRevenue estimate
Valuation estimate
Sachs Associates leadership team
Management profileNumber of profiles
Sachs Associates funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Sachs Associates M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Sachs Associates
What does Sachs Associates do?
Sachs Associates organizes and runs international conferences and forums for the life sciences industry, focused on biotech, medtech, and digital health sectors. Its core deliverable is the SachsForum event platform and the annual forum portfolio (BEF, ELSF, NIF, OCIF, BOIF, IOIF, EHIS, among others), which provide licensing, investment, and partnering opportunities through panel discussions, company presentations, exhibitions, and a One-2-One meeting system for delegates. Revenue is generated from paid corporate registrations, sponsorship packages, exhibition stands, and corporate presentation slots, while qualified institutional investors receive complimentary passes.
Is Sachs Associates a public or private company?
Sachs Associates is a private company. It is classified as unknown and is currently operating.
When was Sachs Associates founded?
Sachs Associates was founded in 1999. It employs 11 to 50 people.
Where is Sachs Associates based?
Sachs Associates is headquartered in London, United Kingdom, in the Europe region.
How does Sachs Associates make money?
Four revenue lines are on record. Conference Registration Fees are the primary driver. The others are sponsorship Packages, exhibition Stands and corporate Presentations.
Who are Sachs Associates's main competitors?
Direct peers on record are EBD Group (BIO Partnering), Cambridge Healthtech Institute (CHI), Hanson Wade, Terrapinn (now Agenda) and BioFIT (Event). Broad incumbents are Informa (Life Sciences / Pharma Intelligence), Drug Information Association (DIA) and BIO (Biotechnology Innovation Organization). Emerging players are Fierce Biotech / Fierce Pharma Events and BioCentury Inc..
Does Sachs Associates have an API?
No public API is recorded for Sachs Associates.
What industry is Sachs Associates in?
Sachs Associates's product category is Life Sciences Conferences and Investor Forums. Its primary akta.pro industry code is MPAGAGAC, Corporate Conferences & Sales Kickoffs, with a secondary code of MPAGAGAK, Executive Summits & Invitation-Only Forums. Its NAICS code is 56192.